Does NEDAPLATIN Cause Myelosuppression? 272 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 272 reports of Myelosuppression have been filed in association with NEDAPLATIN. This represents 36.9% of all adverse event reports for NEDAPLATIN.
272
Reports of Myelosuppression with NEDAPLATIN
36.9%
of all NEDAPLATIN reports
9
Deaths
151
Hospitalizations
How Dangerous Is Myelosuppression From NEDAPLATIN?
Of the 272 reports, 9 (3.3%) resulted in death, 151 (55.5%) required hospitalization, and 33 (12.1%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NEDAPLATIN. However, 272 reports have been filed with the FAERS database.
What Other Side Effects Does NEDAPLATIN Cause?
White blood cell count decreased (61)
Thrombocytopenia (51)
Off label use (49)
Neutropenia (45)
Neutrophil count decreased (41)
Bone marrow failure (35)
Gastrointestinal disorder (35)
Platelet count decreased (35)
Disease progression (33)
Nausea (30)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which NEDAPLATIN Alternatives Have Lower Myelosuppression Risk?
NEDAPLATIN vs NEFAZODONE
NEDAPLATIN vs NEFOPAM
NEDAPLATIN vs NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE\NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIG
NEDAPLATIN vs NELARABINE
NEDAPLATIN vs NELFINAVIR